North America Pressure Ulcer Devices Market Size, Share, and Growth Forecast 2026 - 2033

The North America pressure ulcer devices market size is expected to be valued at US$ 1.7 billion in 2026 and projected to reach US$ 2.8 billion by 2033, growing at a CAGR of 7.3% between 2026 and 2033.

Rising prevalence of hospital-acquired and long-term care-associated pressure injuries is the foremost catalyst behind this sustained market expansion, compounded by an aging population increasingly reliant on institutional and home-based care.

The Agency for Healthcare Research and Quality (AHRQ) estimates that pressure injuries affect approximately 2.5 million patients annually across acute care facilities in the United States, creating substantial demand for preventive and therapeutic devices. Compounding this, the Centers for Medicare & Medicaid Services (CMS) has classified certain hospital-acquired pressure injuries as non-reimbursable conditions since 2008, compelling healthcare facilities to invest proactively in pressure redistribution mattresses, cushions, and monitoring technologies. Simultaneously, growing home healthcare use among aging North Americans is broadening demand for pressure ulcer prevention devices beyond traditional institutional settings.

Drivers - Rising Incidence of Hospital-Acquired Pressure Injuries and CMS Non-Reimbursement Policies

Pressure injuries remain one of the most common and costly hospital-acquired conditions across North America, directly driving demand for preventive devices. The Agency for Healthcare Research and Quality (AHRQ) reports that hospital-acquired pressure injuries add significant treatment costs per affected patient, ranging into the tens of thousands of dollars depending on injury severity, placing substantial financial burden on healthcare systems.

Since 2008, the Centers for Medicare & Medicaid Services (CMS) has excluded certain hospital-acquired pressure injuries from reimbursement eligibility, creating strong financial incentive for hospitals to adopt pressure relief mattresses, cushions, and monitoring devices as standard preventive protocol. This regulatory pressure, combined with growing institutional focus on patient safety metrics tracked by organizations such as the National Pressure Injury Advisory Panel (NPIAP), continues to reinforce sustained procurement of advanced pressure ulcer prevention technologies across hospitals and long-term care facilities throughout the region.

Aging Population and Rising Long-Term Care Facility Utilization

North America's rapidly aging population is substantially increasing the pool of individuals at elevated risk for pressure injuries, particularly those with limited mobility residing in long-term care settings. The U.S. Census Bureau projects continued growth in the population aged 65 and older through 2033, a demographic segment disproportionately affected by immobility-related skin breakdown according to clinical literature indexed by the National Institutes of Health (NIH).

Long-term care facilities, which house a significant share of elderly residents with chronic mobility limitations, are increasingly adopting static and dynamic pressure redistribution surfaces as part of standardized care protocols. As life expectancy continues rising and chronic disease prevalence grows among older adults, demand for pressure relief mattresses, heel protection devices, and repositioning equipment is expected to expand consistently across both hospital and long-term care environments throughout the forecast period.

Restraints - High Cost of Advanced Dynamic Pressure Redistribution Systems

Advanced dynamic pressure redistribution devices, including alternating pressure mattresses and powered patient repositioning systems, carry substantially higher acquisition and maintenance costs than conventional static foam surfaces, restricting adoption among budget-constrained care settings. Reimbursement support under Medicare and Medicaid for durable medical equipment related to pressure ulcer prevention varies considerably by device category and clinical justification, often requiring extensive documentation to secure coverage approval.

Long-term care facilities operating under tight per-resident budget allocations frequently default to lower-cost static devices rather than investing in premium dynamic technologies, even when clinical risk assessments indicate that higher-risk patients could benefit from advanced pressure redistribution. This cost sensitivity is particularly pronounced among smaller, independently operated long-term care facilities, moderating the overall pace of premium device adoption across the North America pressure ulcer devices market.

Inconsistent Risk Assessment Practices and Staffing Shortages in Care Settings

Effective pressure ulcer prevention depends heavily on consistent clinical risk assessment and timely patient repositioning, both of which are increasingly challenged by nursing staffing shortages across North American healthcare facilities. The American Nurses Association has highlighted persistent nurse staffing gaps across hospitals and long-term care settings, directly impacting the frequency and consistency of manual repositioning protocols essential for pressure injury prevention.

Without adequate staffing levels, even well-equipped facilities with advanced pressure relief devices may fail to achieve optimal clinical outcomes, as devices alone cannot fully substitute for consistent nursing oversight and timely intervention. This human-resource constraint particularly affects long-term care facilities and home healthcare settings, where caregiver-to-patient ratios are often lower than in acute hospital environments, thereby moderating the realized clinical and commercial impact of pressure ulcer prevention device investments across the region.

Opportunities - Growing Adoption of Smart Pressure Monitoring and Sensor-Based Technologies

The emergence of smart pressure monitoring devices equipped with continuous sensor-based feedback presents a significant growth opportunity for manufacturers in the North America pressure ulcer devices market. These technologies enable real-time tracking of interface pressure and patient movement, allowing clinicians to intervene proactively before tissue damage occurs, rather than relying solely on scheduled manual repositioning checks.

Companies such as Stryker and Arjo have expanded their portfolios to include connected pressure mapping and monitoring solutions designed for integration with hospital electronic health record systems. As healthcare facilities increasingly prioritize data-driven patient safety protocols to avoid CMS reimbursement penalties associated with hospital-acquired pressure injuries, demand for pressure monitoring devices is expected to accelerate significantly. This technological shift toward continuous, sensor-based prevention represents a durable, high-margin growth avenue for companies investing in digital health integration capabilities.

Expansion of Home Healthcare and Aging-in-Place Care Models

The accelerating shift toward home-based care for elderly and chronically ill patients presents a substantial opportunity for pressure ulcer device manufacturers to expand beyond traditional institutional channels. Growing preference for aging-in-place care models, supported by expanding Medicare home health benefit utilization, is increasing demand for portable and caregiver-friendly pressure relief mattresses, cushions, and repositioning aids suitable for residential settings.

Companies including Drive DeVilbiss Healthcare and Invacare Corporation have expanded home healthcare-focused product lines designed for ease of use by family caregivers and visiting home health aides. As home healthcare agencies across the United States and Canada continue scaling operations to meet rising demand from aging populations, manufacturers offering simplified, cost-effective pressure ulcer prevention devices tailored for non-clinical caregivers are well positioned to capture a growing share of this expanding care delivery channel.

Product Type Analysis

Pressure relief mattresses led the product type segment, commanding approximately 43% share of the North America pressure ulcer devices market in 2025. This dominant position reflects the segment's role as the foundational preventive device used across nearly all high-risk care settings, from hospital intensive care units to long-term care facility resident rooms. The National Pressure Injury Advisory Panel (NPIAP) identifies support surface selection as a core component of evidence-based pressure injury prevention protocols, reinforcing consistent institutional demand for both static foam and dynamic alternating pressure mattress systems.

Leading manufacturers including Hill-Rom (Baxter) and Arjo continue to expand mattress product lines featuring enhanced pressure redistribution technology and integrated microclimate management. Meanwhile, the Pressure Monitoring Devices segment is projected to be the fastest-growing product category driven by rising clinical adoption of sensor-based, real-time pressure tracking technologies.

Technology Analysis

Static Devices represented the leading technology segment, accounting for an estimated 58% share of the North America pressure ulcer devices market in 2026. Static support surfaces, including foam and gel-based mattresses and cushions, maintain this leadership due to their comparatively lower cost, ease of maintenance, and suitability for low-to-moderate risk patients across the majority of hospital and long-term care settings. Clinical guidelines referenced by the Wound, Ostomy and Continence Nurses Society (WOCN) recommend static support surfaces as an appropriate first-line intervention for patients without significant mobility limitations, sustaining broad institutional adoption.

Manufacturers such as Medline Industries and Mölnlycke Health Care continue to expand static device portfolios given their cost-efficiency advantages for large-scale institutional procurement. Dynamic Devices, however, are expected to be the fastest-growing technology segment through 2033, as facilities increasingly deploy alternating pressure systems for higher-acuity patients at elevated pressure injury risk.

End User Analysis

Hospitals emerged as the leading end-user segment, holding approximately 39% share of the North America pressure ulcer devices market in 2025. This leadership position is driven by the high concentration of critically ill and immobile patients within intensive care and surgical recovery units, where pressure injury risk is significantly elevated compared with general care settings. Hospital adoption of pressure relief devices is further reinforced by CMS reimbursement policies that financially penalize institutions for hospital-acquired pressure injuries, creating strong compliance-driven procurement incentives.

Leading device manufacturers, including Stryker and LINET Group, maintain extensive hospital distribution partnerships supporting bundled equipment procurement programs. Home Healthcare, meanwhile, is projected to be the fastest-growing end-user segment through 2033, propelled by the accelerating shift toward aging-in-place care models and expanding home health agency utilization across the United States and Canada.

North America Pressure Ulcer Devices Market Trends and Insights

North America's pressure ulcer devices market is shaped by stringent hospital-acquired condition reimbursement policies, a rapidly aging population, and a mature long-term care infrastructure emphasizing evidence-based prevention protocols. Regulatory pressure from CMS continues to drive institutional investment in advanced pressure redistribution and monitoring technologies, while growing home healthcare use is extending demand beyond traditional hospital and long-term care channels.

Clinical guidelines published by organizations such as the National Pressure Injury Advisory Panel (NPIAP) continue to standardize prevention protocols across care settings, supporting consistent device adoption. Additionally, expanding domestic manufacturing presence from established medical device companies headquartered within the region continues to reinforce North America's position as a mature yet steadily growing market for pressure ulcer prevention and management technologies.

U.S. Pressure Ulcer Devices Market Size

The United States dominated the North America pressure ulcer devices market, accounting for approximately 85% regional share in 2025, supported by an estimated market value exceeding US$ 1.4 billion in 2026. This leadership position is underpinned by stringent CMS hospital-acquired condition reimbursement policies, extensive hospital and long-term care facility infrastructure, and strong clinical guideline adoption promoted by the National Pressure Injury Advisory Panel (NPIAP).

The Agency for Healthcare Research and Quality (AHRQ) continues to report substantial annual pressure injury incidence across American acute care facilities, sustaining institutional demand for preventive mattresses, cushions, and monitoring devices. Additionally, the presence of major device manufacturers such as Hill-Rom (Baxter) and Stryker headquartered domestically further reinforces the country's position as the primary revenue contributor within the North America pressure ulcer devices market.

Canada Pressure Ulcer Devices Market Size

Canada is projected to be the fastest-growing market within North America, supported by expanding public long-term care investment and rising awareness of pressure injury prevention across provincial healthcare systems. The Canadian Association of Wound Care (CAWC) continues to promote standardized pressure injury prevention protocols across Canadian hospitals and long-term care facilities, supporting growing institutional adoption of pressure redistribution devices.

Statistics Canada data highlighting a steadily aging population further reinforces rising demand, as elderly Canadians represent the demographic segment most vulnerable to immobility-related skin breakdown. Provincial healthcare authorities across the country continue modernizing long-term care infrastructure and expanding home care program funding, positioning Canada to grow at an accelerated pace relative to the United States within the broader North America pressure ulcer devices market through the forecast period.

The North America pressure ulcer devices market is moderately consolidated, led by established medical device manufacturers such as Arjo, Hill-Rom (Baxter), and Stryker. Competitive strategy centers on continuous innovation in dynamic support surface technology, integrated pressure monitoring sensors, and microclimate management systems designed to improve clinical outcomes while reducing hospital-acquired condition penalties.

Key differentiators among market leaders include depth of clinical evidence, breadth of institutional distribution networks, and rental and service-based business models that lower upfront capital barriers for healthcare facilities. Emerging business trends include growing integration of digital monitoring capabilities with hospital information systems and expanding rental fleet offerings, allowing facilities to access advanced dynamic devices without significant capital expenditure.

Key Developments:

• February 2025: Arjo launched an updated line of alternating pressure mattress systems featuring integrated sensor technology for continuous patient monitoring across North American hospital networks.
• October 2024: Stryker expanded its patient handling and pressure redistribution equipment portfolio following the launch of a new powered repositioning system for acute care settings.
• June 2024: Hill-Rom (Baxter) introduced an enhanced hospital bed and mattress integration platform designed to improve pressure injury prevention protocols in intensive care units.